Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke

Inclusion Criteria: * Aged \> 18 years and \< 85 years, regardless of gender * Meeting the diagnostic criteria for ischemic stroke in Western medicine * Meeting the diagnostic criteria for stroke (Zhongfeng) in Traditional Chinese Medicine (TCM) * Diagnosis of acute ischemic stroke within 72h of symptom onset * A score of 4-25 points on the National Institute of Health Stroke Scale (NIHSS) * First onset of the disease, or no severe sequelae related to previous onset * The patient and their legal guardian voluntarily sign the informed consent form for the study Exclusion Criteria: * Confirmed by cranial imaging examination to have diseases causing similar symptoms such as brain tumors, encephalitis, and brain abscesses; or confirmed to have hemorrhagic cerebral infarction,epidural hematoma,intracranial hematoma, intraventricular hemorrhage, subarachnoid hemorrhage, etc. * Patients with severe abnormalities of liver and kidney function (liver function: alanine aminotransferase \[ALT\] \>2 times the upper limit of normal \[ULN\]; renal function: creatinine \[Cr\]\>1.5 times the upper limit of normal \[ULN\]) * Elderly patients with physical weakness or patients complicated with infection * Patients with a history of mental illness or dementia * Patients with other severe organ or systemic diseases, accompanied by malignant tumors in any organ or system, or undergoing anti-tumor treatment, with an expected survival time of \< 6 months * A significant history of drug or alcohol abuse * Women who test positive for blood human chorionic gonadotropin (HCG) (i.e., HCG ≥ 5 mIU/mL) during pregnancy screening, plan to become pregnant during the trial, or are breastfeeding * Patients who are currently participating in other clinical trials or have participated in other clinical trials within the past 1 month * Patients who are currently using other cholinesterase inhibitor drugs or have used other cholinesterase inhibitor drugs within the past 3 months * Patients with epilepsy, hyperkinesis, mechanical intestinal obstruction, bronchial asthma, angina pectoris, bradycardia, or glaucoma * Patients with contraindications to brain magnetic resonance imaging (MRI) examination, such as patients with implanted cardiac pacemakers, patients with implanted artificial joints or orthopedic plates, patients with claustrophobia, etc